首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1722463

2025-2033年生物技術市場報告（依產品類型、技術、應用和地區）

Biotechnology Market Report by Product Type, Technology, Application, and Region 2025-2033

出版日期: 2025年05月01日 | 出版商:

IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2024年全球生技市場規模達7,615億美元。展望未來， IMARC Group預計到2033年市場規模將達到13,159億美元，2025-2033年期間的成長率（CAGR）為6.27%。個人化醫療研發 (R&D) 的不斷增加、基因工程的眾多進步以及對永續農業的需求不斷成長是推動市場發展的一些主要因素。

生物技術是一個多學科領域，涵蓋利用生物體、細胞和生物系統來開發創新產品和技術。它涉及利用分子和細胞層面的生物過程和生物體來應對醫療保健、農業和環境管理等行業的各種挑戰。生物技術包括基因工程、生物製藥、生物資訊學和合成生物學等領域，旨在創造新的解決方案、改善現有流程並增進我們對生命系統的理解。該領域在塑造現代醫學、永續農業以及多種應用的新材料的開發中發揮著至關重要的作用。

由於基因研究和分子生物學理解的快速進步，基因編輯、個人化醫療和新療法等領域的創新不斷湧現，將在預測期內刺激市場成長。此外，慢性病盛行率的上升和針對性治療的需求增加了對生物製藥和精準醫療的需求，從而對市場成長產生了積極影響。此外，由於全球人口不斷成長和可耕地面積有限，對永續農業解決方案的需求不斷增加，加速了生物技術在作物改良和生物農藥中的應用。除此之外，生物技術與資訊技術的融合（即生物資訊學）增強了數據驅動的研究和開發洞察力，正在推動市場成長。此外，由於對環境永續性的關注度不斷提高，生物修復方法和生物燃料的發展也促進了市場的成長。

生物技術市場趨勢/促進因素：

基因工程的快速進步

基因工程的顯著進步，以革命性的 CRISPR-Cas9 技術為突出代表，代表了生物技術市場的主要驅動力。這項技術使科學家能夠精確地修改生物體內的基因，為醫學、農業和工業過程的應用帶來了前所未有的潛力。在醫療保健領域，基因工程促進了針對遺傳疾病和癌症的創新基因療法的開發，為個人化治療提供了一個有希望的途徑。此外，透過改造微生物來生產胰島素和酵素等有價值化合物的能力已經改變了製藥和工業製造。

個人化醫療和治療的需求不斷增加

根據個人基因組成客製化的個人化醫療概念在生物技術市場越來越受到關注。基因組定序技術的進步使得分析個人遺傳密碼和識別與疾病相關的遺傳變異成為可能。這導致了針對患者獨特遺傳特徵的標靶療法的發展，提高了治療效果並減少了不良反應。生物技術使得單株抗體和基因療法等生物製藥的生產成為可能，符合個人化醫療的原則。此外，基於基因標記的診斷可以實現早期疾病檢測和預測，從而重塑醫療保健實踐，使其更加精確和個人化。

對永續農業解決方案的需求日益成長

全球對糧食的需求不斷成長，加上對環境問題的擔憂和對永續農業實踐的需求，推動了農業領域採用生物技術解決方案。為提高產量、抗蟲害能力和營養成分而進行的基因改造作物（GMO）是生物技術對農業影響的例子。源自天然生物的生物農藥由於對環境的影響較小，比傳統化學農藥更受青睞。生物技術提供了最佳化植物特性、提高作物對氣候變遷的適應能力和增加養分效率的工具，有助於糧食安全和資源永續性。這一促進因素反映了生物技術在解決農業領域緊迫挑戰同時最大限度地減少生態足跡方面發揮的關鍵作用。

The global biotechnology market size reached USD 761.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 1,315.9 Billion by 2033, exhibiting a growth rate (CAGR) of 6.27% during 2025-2033. The increasing research and development (R&D) in personalized medicine, numerous advancements in genetic engineering, and escalating demand for sustainable agriculture are some of the major factors propelling the market.

Biotechnology is a multidisciplinary field that encompasses the use of living organisms, cells, and biological systems to develop innovative products and technologies. It involves harnessing biological processes and organisms at the molecular and cellular level to address various challenges across industries, such as healthcare, agriculture, and environmental management. Biotechnology includes areas like genetic engineering, biopharmaceuticals, bioinformatics, and synthetic biology, all aimed at creating new solutions, improving existing processes, and advancing our understanding of living systems. This field plays a crucial role in shaping modern medicine, sustainable agriculture, and the development of novel materials for diverse applications.

The rising innovation in areas, including gene editing, personalized medicine, and novel therapies, due to rapid advancements in genetic research and the understanding of molecular biology, will stimulate the market growth during the forecast period. Moreover, the increasing prevalence of chronic diseases and the need for targeted treatments have augmented the demand for biopharmaceuticals and precision medicine, thus positively influencing the market growth. Additionally, the heightening demand for sustainable agricultural solutions owing to the expanding global population and limited arable land has accelerated the adoption of biotechnological techniques in crop improvement and biopesticides. Apart from this, the convergence of biotechnology with information technology, known as bioinformatics, that enhances data-driven insights for research and development is propelling the market growth. Furthermore, the development of bioremediation methods and biofuels on account of the escalating focus on environmental sustainability is contributing to market growth.

Biotechnology Market Trends/Drivers:

Rapid advancements in genetic engineering

The remarkable progress in genetic engineering, prominently exemplified by the revolutionary CRISPR-Cas9 technology, represents a primary driver in the biotechnology market. This technique allows scientists to precisely modify genes within organisms, presenting unprecedented potential for applications in medicine, agriculture, and industrial processes. In healthcare, genetic engineering facilitates the development of innovative gene therapies for genetic disorders and cancers, offering promising avenues for personalized treatments. Moreover, the ability to engineer microbes for the production of valuable compounds like insulin and enzymes has transformed pharmaceutical and industrial manufacturing.

Increasing demand for personalized medicine and therapeutics

The concept of personalized medicine, tailored to an individual's genetic makeup, is gaining traction in the biotechnology market. Advancements in genomic sequencing technologies have made it possible to analyze an individual's genetic code and identify genetic variations linked to diseases. This has led to the development of targeted therapies that address the unique genetic characteristics of patients, enhancing treatment efficacy and reducing adverse effects. Biotechnology enables the production of biopharmaceuticals such as monoclonal antibodies and gene therapies, aligning with the principles of personalized medicine. Additionally, diagnostics based on genetic markers allow for early disease detection and prognosis, reshaping healthcare practices toward more precise and individualized approaches.

Rising need for sustainable agriculture solutions

The increasing global demand for food, coupled with environmental concerns and the need for sustainable agricultural practices, fuels the adoption of biotechnological solutions in farming. Genetically modified crops (GMOs) engineered for enhanced yield, pest resistance, and nutritional content are examples of biotechnology's influence on agriculture. Biopesticides derived from naturally occurring organisms are gaining preference over traditional chemical pesticides owing to their reduced environmental impact. Biotechnology offers tools to optimize plant traits, improve crop resilience to climate change, and increase nutrient efficiency, contributing to food security and resource sustainability. This driver reflects the critical role of biotechnology in addressing pressing challenges within the agriculture sector while minimizing ecological footprints.

Biotechnology Industry Segmentation:

Breakup by Product Type:

Instruments
Reagents
Software and Services

Instruments form the foundation of advanced research and diagnostics, enabling precise analysis and experimentation. Reagents are essential components that fuel experimental processes, facilitating accurate results and breakthroughs. Software plays a pivotal role, providing data analysis, visualization, and integration solutions, enhancing efficiency and accuracy in biotechnological endeavors. Services encompass consulting, training, and technical support, nurturing collaboration and aiding in the effective utilization of tools.

Furthermore, these components synergistically push the boundaries of biotechnology, fostering innovation and driving advancements that impact diverse sectors such as healthcare, agriculture, and environmental sciences. As the industry evolves, the strategic interplay of instruments, reagents, software, and services continues to shape the trajectory of biotechnology, fueling growth, discovery, and progress.

Breakup by Technology:

Nanobiotechnology
Tissue Engineering and Regeneration
DNA Sequencing
Cell-Based Assays
Fermentation
PCR Technology
Chromatography
Others

Nanobiotechnology integrates nanoscale materials with biological systems, revolutionizing drug delivery, diagnostics, and therapies. Tissue engineering and regeneration pioneers novel approaches for creating functional tissues, addressing organ shortages and medical needs. DNA sequencing enables comprehensive genomic analysis, guiding personalized medicine and disease understanding. Cell-based assays provide insights into cellular behavior, supporting drug development and toxicity testing. Fermentation is a cornerstone for bioprocessing, producing biofuels, pharmaceuticals, and enzymes. PCR Technology amplifies DNA, underpinning diagnostics and genetic research.

Chromatography separates biomolecules with precision, crucial in drug purification and analytical processes. These intertwined advancements drive the market's progress, fostering innovation and solutions across healthcare, agriculture, and environmental sectors.

Breakup by Application:

Healthcare
Food and Agriculture
Natural Resources and Environment
Industrial Processing
Bioinformatics
Others

Healthcare dominates the market

Healthcare serves as a pivotal driving force behind the biotechnology market, catalyzing innovations that transform patient care and medical practices. Biotechnology solutions play a vital role in diagnostics, treatment development, and personalized medicine. From advanced DNA sequencing enabling precise disease identification to biopharmaceuticals revolutionizing treatment modalities, the synergy between healthcare and biotechnology yields breakthrough therapies, improved patient outcomes, and enhanced disease management.

As healthcare and biotechnology intertwine, novel discoveries in areas such as gene editing, synthetic biology, and biomarker development further propelling the market growth. The biotechnology sector's continual evolution addresses current medical challenges and paves the way for future advancements, shaping the landscape of healthcare delivery and underscoring its significance as a critical driver of progress within the biotechnology domain.

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest share in the market since the region boasts a robust ecosystem of research, innovation, and industry collaboration. The region's strong investment in research and development (R&D), coupled with its well-established regulatory frameworks, fosters an environment conducive to biotechnological breakthroughs. Various leading universities, research institutions, and biotech companies converge to push the boundaries of scientific discovery and technological advancements.

Furthermore, the rising emphasis of the North America region on entrepreneurship and venture capital further accelerates the commercialization of novel biotech solutions. With a history of pioneering achievements in areas such as genomics, pharmaceuticals, and medical devices, North America's influential role continues to shape the global biotechnology landscape, catalyzing growth, fostering innovation, and driving positive societal and economic impacts.

Competitive Landscape:

Key players in the biotechnology market have introduced groundbreaking innovations. Leading biopharmaceutical companies are developing mRNA-based vaccines that demonstrated remarkable efficacy in pandemic response. Additionally, advancements in CRISPR-based gene editing techniques have enabled precise and efficient modifications in various organisms, promising transformative applications in genetic therapies and modified crops. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) in drug discovery and development processes is accelerating the identification of potential drug candidates. These innovations reflect the industry's commitment to addressing global challenges, ranging from disease outbreaks to food security, through cutting-edge biotechnological solutions with the potential to reshape medical treatments, agriculture practices, and industrial processes. We also expect the market to witness new entrants, consolidation of portfolios, and an increase in strategic partnerships and collaborations among vendors to drive healthy competition within the domain during the forecast period.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Amgen Inc.
Biocon Limited
Biogen Inc.
F. Hoffmann-La Roche AG
Genmab A/S
Lonza Group AG
Novartis AG
Novo Nordisk A/S
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Seagen Inc.
Syngenta AG
Vertex Pharmaceuticals Incorporated

Recent Developments:

In May 2022, F. Hoffmann-La Roche Ltd, a leading healthcare enterprise headquartered in Switzerland, introduced the innovative breast cancer antibody cocktail drug, PHESGO, to the Indian market. This breakthrough offering comes with a compelling advantage, as it is not only priced at a remarkable 20% lower than existing therapies but also offers a more streamlined and convenient administration process. It specifically targets HER-2 positive breast cancer, a challenging and prevalent subtype, while holding the distinction of being sanctioned for both early and advanced stages, including metastatic cases.

In January 2021, Novartis AG, a renowned pharmaceutical leader, entered into a strategic collaboration with Alnylam, a pioneering biotechnology company specializing in RNA interference (RNAi) technology. This innovative partnership aims to harness Alnylam's cutting-edge small interfering RNA (siRNA) technology to pave the way for a revolutionary targeted therapy. The focus of this collaboration centers on restoring optimal liver function, a critical aspect in numerous medical conditions.

In Jan 2023, Pfizer Inc., a global leader in biopharmaceuticals, collaborated with Gero, an avant-garde biotechnology company renowned for its advanced technology platform. This strategic research collaboration marks a convergence of expertise and technology, aiming to unlock new insights into the complex realm of fibrotic diseases. By harnessing Pfizer's extensive domain knowledge and Gero's state-of-the-art machine-learning capabilities, the partnership endeavors to chart unexplored territories in the understanding of genes and pathways linked to fibrosis - a group of disorders characterized by tissue scarring and dysfunction.

Key Questions Answered in This Report

1.How big is the biotechnology market?
2.What is the expected growth rate of the global biotechnology market during 2025-2033?
3.What are the key factors driving the global biotechnology market?
4.What has been the impact of COVID-19 on the global biotechnology market?
5.What is the breakup of the global biotechnology market based on the application?
6.What are the key regions in the global biotechnology market?
7.Who are the key players/companies in the global biotechnology market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Biotechnology Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type

6.1 Instruments
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Reagents
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Software and Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Technology

7.1 Nanobiotechnology
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Tissue Engineering and Regeneration
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 DNA Sequencing
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Cell-Based Assays
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Fermentation
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 PCR Technology
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
7.7 Chromatography
- 7.7.1 Market Trends
- 7.7.2 Market Forecast
7.8 Others
- 7.8.1 Market Trends
- 7.8.2 Market Forecast

8 Market Breakup by Application

8.1 Healthcare
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Food and Agriculture
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Natural Resources and Environment
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Industrial Processing
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Bioinformatics
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
8.6 Others
- 8.6.1 Market Trends
- 8.6.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Amgen Inc.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
- 14.3.2 Biocon Limited
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 Biogen Inc.
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 F. Hoffmann-La Roche AG
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
- 14.3.5 Genmab A/S
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 Lonza Group AG
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis
- 14.3.7 Novartis AG
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT Analysis
- 14.3.8 Novo Nordisk A/S
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
  - 14.3.8.4 SWOT Analysis
- 14.3.9 Pfizer Inc.
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis
- 14.3.10 Regeneron Pharmaceuticals Inc.
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 Financials
  - 14.3.10.4 SWOT Analysis
- 14.3.11 Seagen Inc.
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
  - 14.3.11.3 Financials
  - 14.3.11.4 SWOT Analysis
- 14.3.12 Syngenta AG
  - 14.3.12.1 Company Overview
  - 14.3.12.2 Product Portfolio
  - 14.3.12.3 SWOT Analysis
- 14.3.13 Vertex Pharmaceuticals Incorporated
  - 14.3.13.1 Company Overview
  - 14.3.13.2 Product Portfolio
  - 14.3.13.3 Financials
  - 14.3.13.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Biotechnology Market: Major Drivers and Challenges
Figure 2: Global: Biotechnology Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Biotechnology Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Biotechnology Market: Breakup by Product Type (in %), 2024
Figure 5: Global: Biotechnology Market: Breakup by Technology (in %), 2024
Figure 6: Global: Biotechnology Market: Breakup by Application (in %), 2024
Figure 7: Global: Biotechnology Market: Breakup by Region (in %), 2024
Figure 8: Global: Biotechnology (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Biotechnology (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Biotechnology (Reagents) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Biotechnology (Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Biotechnology (Software and Services) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Biotechnology (Software and Services) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Biotechnology (Nanobiotechnology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Biotechnology (Nanobiotechnology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Biotechnology (Tissue Engineering and Regeneration) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Biotechnology (Tissue Engineering and Regeneration) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Biotechnology (DNA Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Biotechnology (DNA Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Biotechnology (Cell-Based Assays) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Biotechnology (Cell-Based Assays) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Biotechnology (Fermentation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Biotechnology (Fermentation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Biotechnology (PCR Technology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Biotechnology (PCR Technology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Biotechnology (Chromatography) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Biotechnology (Chromatography) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Biotechnology (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Biotechnology (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Biotechnology (Healthcare) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Biotechnology (Healthcare) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Global: Biotechnology (Food and Agriculture) Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Global: Biotechnology (Food and Agriculture) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Global: Biotechnology (Natural Resources and Environment) Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Global: Biotechnology (Natural Resources and Environment) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Global: Biotechnology (Industrial Processing) Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Global: Biotechnology (Industrial Processing) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Global: Biotechnology (Bioinformatics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Global: Biotechnology (Bioinformatics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: Global: Biotechnology (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: Global: Biotechnology (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: North America: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: North America: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: United States: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: United States: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Canada: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Canada: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Asia-Pacific: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Asia-Pacific: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: China: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: China: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Japan: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Japan: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: India: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: India: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: South Korea: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: South Korea: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Australia: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Australia: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Indonesia: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Indonesia: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Others: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Others: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Europe: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Europe: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Germany: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Germany: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: France: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: France: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: United Kingdom: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: United Kingdom: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Italy: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Italy: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Spain: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Spain: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Russia: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Russia: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Others: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 79: Others: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 80: Latin America: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 81: Latin America: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 82: Brazil: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 83: Brazil: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 84: Mexico: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 85: Mexico: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 86: Others: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 87: Others: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 88: Middle East and Africa: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 89: Middle East and Africa: Biotechnology Market: Breakup by Country (in %), 2024
Figure 90: Middle East and Africa: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 91: Global: Biotechnology Industry: SWOT Analysis
Figure 92: Global: Biotechnology Industry: Value Chain Analysis
Figure 93: Global: Biotechnology Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Biotechnology Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Biotechnology Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
Table 3: Global: Biotechnology Market Forecast: Breakup by Technology (in Million USD), 2025-2033
Table 4: Global: Biotechnology Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 5: Global: Biotechnology Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Biotechnology Market: Competitive Structure
Table 7: Global: Biotechnology Market: Key Players

02-2729-4219

+886-2-2729-4219